pbacchetti@epi.ucsf.edu
(415) 476-9844 (voice)
(415) 476-6014 (fax)

Box 0560, UCSF; San Francisco, CA 94143-0560

University of California, Berkeley, California, BA, 1980, Philosophy and Statistics
Stanford University, Stanford, California, MS, 1982, Statistics
University of California, Berkeley, California, PhD, 1987, Biostatistics

Bacchetti P, Osmond D, Chaisson RE, Dritz S, Rutherford GW, Swig L, Moss AR. Survival patterns of the first 500 patients with AIDS in San Francisco. Journal of Infectious Diseases, 157:1044-1047, 1988.

Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association, 261:561-565, 1989.

Bacchetti P and Moss AR. Incubation period of AIDS in San Francisco. Nature, 338:251-253, 1989.

Bacchetti P. Additive isotonic models. Journal of the American Statistical Association, 84:289-294, 1989.

Bacchetti P. Estimating the incubation period of AIDS by comparing population infection and diagnosis patterns. Journal of the American Statistical Association, 85:1002-1008, 1990.

Bacchetti P and Jewell NP. Nonparametric estimation of the incubation period of AIDS based on a prevalent cohort with unknown infection times. Biometrics, 47:947-960, 1991.

Bacchetti P, Moss AR, Andrews JC, Jacobson MA. Early predictors of survival in symptomatic HIV-infected persons Treated with high-dose zidovudine. J Acq Imm Def Synd, 5:732-736, 1992.

Bacchetti P, Segal MR, Hessol NA, Jewell NP. Different AIDS incubation periods and their impacts on reconstructing HIV epidemics and projecting AIDS incidence. PNAS USA, 90:2194-2196, 1993.

Bacchetti P, Segal MR, Jewell NP. Backcalculation of HIV infection rates. Statist Science, 8:82-119,1993.

Bacchetti P. The impact of lengthening AIDS reporting delays and uncertainty about underreporting on incidence trends and projections. Journal of Acquired Immune Deficiency Syndromes, 7:860-865, 1994.

Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. IFN-ÄÀ Therapy for Hepatitis C Virus Infection Following Liver Transplantation. Hepatol, 20: 773-779, 1994.

Bacchetti P. Seasonal and other short-term influences on US AIDS incidence. Stat Med, 13:1921-31, 1994.

Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, Polito A, Thaler MM, Bacchetti P, et al. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and Relationship to Patient Survival. Hepatology, 20: 1152-5, 1994.

Bacchetti P. Historical assessment of some specific methods for projecting the AIDS epidemic. American Journal of Epidemiology, 141:776-81, 1995.

Bacchetti P, Segal MR. Survival trees with time-dependent covariates: application to estimating changes in the incubation period of AIDS. Lifetime Data Analysis, 1:35-47, 1995.

Bacchetti P. Reporting delay of deaths with AIDS in the United States. J AIDS & HR, 13:363-367, 1996.

Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. Journal of the American Medical Association, 277:478-481, 1997.

Bacchetti P. Incidence of HIV-related deaths in the United States: seasonality and trend. Stat Med, 16:645-52, 1997.

Greenblatt RM, Bacchetti P, Barkan S, et al. Lower genital tract infections among HIV-infected and high risk-uninfected women: findings of the Womenfs Interagency HIV Study (WIHS). Sexually Transmitted Diseases, 26: 143-151, 1999

Greenblatt RM, Ameli N, Grant RM, Bacchetti P, Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. Journal of Infectious Diseases, 181:82-90, 2000.

Morris AM, Huang L, Bacchetti P, Turner J, Hopewell PC, Wallace JM, Kvale PA, Rosen MJ, Glassroth J, Reichman LB, Stansell JD. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. Am J Respir Crit Care Med, 162:612-616, 2000

Bacchetti P. Unexamined assumptions in explorations of upper limit for cases of variant Creutzfeldt-Jakob disease. (Invited commentary). Lancet, 357:3-4, 2001.

Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV among street-recruited injection drug users in San Francisco, 1986 through 1998. Lancet, 357:1397-401, 2001.

Yao FY, Ferrell L, Watson JJ, Bacchetti P, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 33:1394-403, 2001.

Vittinghoff E, Hessol NA, Bacchetti P, Fusaro R, Holmberg SD, Buchbinder SP. Cofactors for HIV disease progression in a cohort of homosexual and bisexual men. J Acq Imm Def Syn, 27:308-14, 2001.

OfHare A, Hsu C-Y, Bacchetti P, Johansen KL. Peripheral Vascular Disease Risk Factors in Hemodialysis Patients. J Am Soc Nephrol, 13:497-503, 2002.

Bacchetti P. Peer review of statistics in medical research: the other problem. BMJ, 324:1271-1273, 2002.

Bacchetti P, Quale C. Generalized additive models with interval-censored data and time-varying covariates: application to HIV infection in hemophiliacs. Biometrics, 58:443-447, 2002.

Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis, 35: 313-22, 2002.

Lee KP, Schotland M, Bacchetti P, Bero LA. Association of Journal Quality Indicators with Methodological Quality of Clinical Research Articles. J Am Med Assoc, 287:2805-2808, 2002.

Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl, 8:765-74, 2002.

Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of HAART. JAIDS, 31: 171-177, 2002

Kral AH, Lorvick J, Gee L, Bacchetti P, Rawal B, Busch M, Edlin BR. Trends in HIV Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987 through 1998. Am J Epi, 157:915-922, 2003.

Feldman JG, Gange SJ, Bacchetti P, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr, 33:66-73, 2003.

Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbiek T, Aweeka FT, Benowitz NL, Bredt BM, Mitchell TM, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Internal Medicine, 139:258-66, 2003.

Bacchetti P. Age and variant Creutzfeldt-Jakob disease. Emerging Infectious Diseases, 9:1611-12, 2003.

Tsui R, Herring BL, Barbour JD, Grant RM, Bacchetti P, Kral A, Edlin BR, Delwart EL. HIV-1 superinfection was not detected following 215 years of injection drug user exposure. J Virol 78:94-103, 2004.

Bacchetti P. Uncertainty due to model choice in variant Creutzfeldt-Jakob disease projections. Stat Med, in press.

Bacchetti P, Wolf LE, Segal MR, McCulloch CE. Ethics and sample size. Am J Epidemiol, in press.

1/5/05